MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cipla
Cipla
BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 29, 13:46
311.00
-1.9 (-0.61%)
VOLUME 41,177
LIVE
NSE
May 29, 13:46
310.25
-3.3 (-1.05%)
VOLUME 884,014
Business News on Cipla
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Cipla considers price cuts on more cancer drugs

3.32 pm | 08 May 2012 |  Source: Reuters

Generic drugmaker Cipla is looking into cutting prices of more cancer drugs after it slashed the prices last week of three treatments by up to 75%, YK...

Cipla drug price cut not to hurt revenue much, say analysts

1.02 pm | 04 May 2012 |  Source: Moneycontrol.com

Cipla's shocking 75% price cut of three cancer drugs on Thursday is unlikely to have a major impact on its earnings, analysts say....

Cipla cuts generic Nexavar price by 75% in India

5.00 pm | 03 May 2012 |  Source: Reuters

Cipla has cut the price of the generic version of Bayer's renal cancer drug Nexavar by 75 percent and will sell it at 6,840 rupees for a monthly dose,...

Ranbaxy launches malaria drug Synriam

4.26 pm | 25 Apr 2012 |  Source: Reuters

Ranbaxy Laboratories, India's top drugmaker by sales, said it launched a new malaria treatment drug Synriam in the country and was working to introduc...

Cipla launches anti-malarial drug in India 

2.08 pm | 25 Apr 2012 |  Source: CNBC-TV18

In an interview to CNBC-TV18, YK Hamied, chairman and managing director of Cipla says, the company is launching an anti-malarial drug in India. "Today...

1
Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.